|David L. Cohen: Nominated Chairman of the Trustees
December 9, 2008,
Volume 55, No. 15
David L. Cohen, EVP of Comcast Corporation, has been nominated to become chairman of the Board of Trustees of the University of Pennsylvania effective November 7, 2009, following the conclusion of the trustees’ fall meetings.
James S. Riepe, chairman of Penn’s trustees, made the announcement. Mr. Riepe, senior advisor and retired vice chairman of T. Rowe Price Group, has been Penn’s board chair since 1999.
“David Cohen has been a long-standing and committed member of Penn’s board and will be a strong leader for the trustees and wise counsel to the University leadership,” Mr. Riepe said. “I’m looking forward to working closely with him between now and next November to ensure a seamless transition.
“Through his work and demonstrated commitment,” Mr. Riepe said, “David has earned the respect of his fellow Penn trustees, particularly in his role as chair of the Penn Medicine board. He brings the right combination of skills to the challenges that Penn and higher education will face in the years ahead.”
“Penn is blessed with an exceptionally strong, engaged and generous board, united in their passion for Penn, and no one epitomizes these qualities more than Jim Riepe,” President Amy Gutmann said. “We are extremely thankful for Jim’s leadership and very grateful that he will continue his unstinting service to Penn as a member of our board after his chairmanship concludes next November. Jim will leave big shoes to fill, but we are secure in the knowledge that David Cohen possesses everything one could want in a new chair, including a love for Penn and a well-earned reputation as a thoughtful, collaborative and incisive leader.”
Mr. Cohen, L’81, has been an active trustee since 2001. In 2002, he was named founding chairman of the board and executive committee of Penn Medicine where he worked closely with University and Penn Medicine leadership to design and implement a successful financial turnaround at the Health System and has played an important role in strengthening Penn Medicine’s infrastructure.